Observational studyLancet (London, England)2021

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.

Noam Barda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.